Ndufa6 regulates adipogenic differentiation via Scd1

Area of Science:

• Biochemistry
• Cell Biology
• Metabolic Diseases

Background:

• Obesity is a global pandemic with serious health complications.
• Inhibiting adipogenesis, the process of fat cell formation, is a key strategy for obesity treatment.
• The precise molecular mechanisms governing adipogenesis are not fully understood, leaving potential therapeutic targets undiscovered.

Purpose of the Study:

• To investigate the functional genes regulating adipogenic differentiation.
• To elucidate the molecular mechanisms underlying adipogenesis.
• To identify novel therapeutic targets for obesity treatment.

Main Methods:

• Utilized transcriptomics and lipidomics to analyze gene expression and lipid profiles.
• Employed OP9 cells and adipose-derived stem cells for experimental models.
• Investigated the role of NADH:ubiquinone oxidoreductase subunit A6 (Ndufa6) in adipogenesis.

Main Results:

• Identified Ndufa6 as a significant regulator of adipogenic differentiation.
• Demonstrated that Ndufa6 exerts its effects via stearoyl-CoA desaturase 1 (Scd1).
• Confirmed the inhibitory effect of a SCD1 inhibitor on adipogenesis.

Conclusions:

• Ndufa6 plays a crucial role in regulating adipogenesis.
• The NDUFA6-SCD1 axis represents a novel pathway in adipogenesis.
• The NDUFA6-SCD1 interaction presents a potential therapeutic target for managing obesity.